Hepatitis C
5 competing products in clinical development for Hepatitis C.
Pipeline by Phase
Phase 11
Phase 22
Phase 31
Approved1
All Products (5)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Interferon alfacon-1 | Astellas Pharma | Phase 3 | Completed | 40 |
| FK788 | Astellas Pharma | Phase 2 | Completed | 35 |
| Pegylated Interferon + Ribavirin | Astellas Pharma | Approved | Withdrawn | 35 |
| Tacrolimus + steroids, monoclonal anti-IL2R antibody | Astellas Pharma | Phase 2 | Completed | 35 |
| MK-2248 | Merck | Phase 1 | Completed | 29 |